KLOW
GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg
≥ 99.2% · Lyophilized powder
- HPLC-verified purity — ≥ 99.2% on this lot
- Lot-numbered — Lot 0480 — traceable end to end
- North American manufactured — Shipped from Ontario, Canada
FOR RESEARCH USE ONLY · NOT INTENDED FOR HUMAN CONSUMPTION. Sold for laboratory and research purposes only.
What's in the vial.
- Compound
- KLOW
- Lane
- Stacks
- Composition
- GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg
- Available sizes
- 80 mg
- Purity (HPLC)
- ≥ 99.2%
- Form
- Lyophilized powder
- Lot
- 0480
- Storage
- Cold, away from light
Co-supplied preparation of GHK-Cu, BPC-157, TB-500 and KPV. Supplied as lyophilized powder for laboratory research use only. Independently assayed for purity and identity.
KLOW.
A four-compound preparation adding KPV — a tripeptide fragment of α-MSH — to the GLOW combination.
Research context
Extends the GLOW preparation with an additional immunomodulatory-research tripeptide.
Handling & storage
Reconstitute with bacteriostatic or sterile water. Protect from light — copper complexes are photosensitive. Store lyophilized powder at −20 °C.
Note
Descriptions are provided for laboratory reference only and describe the compound and the research field in which it appears. Nothing here is a recommendation, protocol, or statement of effect.
